$BETA

BETA Technologies Inc (BETA) (Q2 2026) Earnings Call Highlights: Revenue Surges 146%

Beta Technologies (BETA) reported Q2 2026 revenue of $14.7 million, up 146% year over year and above guidance, driven by EPFD program and charger deliveries. Backlog was 1,001 aircraft worth $3.9 billion. Adjusted EBITDA was -$110 million, with full-year guidance widened to -$400 million to -$445 million. Certification and cash burn remain key risks.

Original reporting
Published Aug 12, 2026, 11:02 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 12:36 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
BETA Technologies Inc (BETA) (Q2 2026) Earnings Call Highlights: Revenue Surges 146% — source image
Decision brief

The 30-second read

$BETANeutralMed
01

Why it matters

Traders should focus on the combination of (1) upside signals like revenue growth, backlog nearing $4B, and concurrent certification possibility, versus (2) downside signals like deeply negative adjusted EBITDA, widened full-year guidance, and pending FAA approvals plus non-finalized EXIM financing.

02

Market read

This is a company-specific earnings update with concrete operating metrics and guidance changes, likely driving repricing around growth versus cash burn and certification execution.

03

What to watch

EXIM financing is described as planned but not finalized, and the ramp rate for demonstrated production is unchanged, both of which can dominate valuation despite backlog growth.

Relevance 8/10Novelty 7/10Timing: post-earnings call, after-hours Aug 12

Background

BETA Technologies held its Q2 2026 earnings call, covering revenue/backlog, certification progress for H500A and CX-300, EIPP operations with United Therapeutics, charging-network expansion, and defense platform MV-250 updates.

Company-level read

Ticker impact

$BETANeutralMedium confidence
Context

BETA reported Q2 revenue of $14.7M (+146% YoY), a $3.9B backlog, and widened full-year adjusted EBITDA guidance to -$400M to -$445M.

Expected impact

Near-term volatility likely, with upside bias from revenue/backlog and downside pressure from widened EBITDA losses and pending FAA approvals.

Evidence & confidence

Revenue and backlog targets improved, but the company reiterated deeply negative adjusted EBITDA, high operating expenses, and that key certification tests and FAA sign-offs remain pending.

Market effects

Highlights ongoing commercialization and certification bottlenecks in advanced air mobility and electric aviation, which can affect sentiment toward the broader AAM supply chain.

Limited direct regional read-through; defense and certification progress may influence US aerospace/defense sentiment.

EIPP and charging-network expansion signals international scaling of electric aviation infrastructure, but the immediate impact is company-specific.

Counterpoint

The revenue surge may not translate into near-term profitability, and the widened EBITDA range suggests cash burn and certification timing could still disappoint.

Key entities

  • BETA Technologies Inc

    Subject of the earnings call highlights, including Q2 financials, backlog, certification milestones, and guidance.

  • United Therapeutics

    Partner referenced for EIPP operations launch with BETA.

  • Archer

    Partner referenced in the joint charger announcement and charging-network standardization.

  • GE Aerospace

    Partner referenced for hybrid electric engine collaboration and MV-250-related power systems.

  • General Dynamics

    Partner referenced for defense and component sales expansion.

Related articles

$BETAMed

BETA Technologies Q2 Earnings Call Highlights

BETA Technologies (NYSE:BETA) reported Q2 progress on FAA-related testing for its CX300 and said H500A certification has not delayed the CX300 program. Backlog ended at 1,001 aircraft and $3.9B, targeting $4B year-end. It cited eIPP organ transport with United Therapeutics, 138 charging sites, and Q3 guidance of $8M-$12M revenue and adj. EBITDA of -$115M to -$125M.

$BETAMed

BETA Posts $149 Million Quarterly Loss

BETA Technologies reported a Q2 2026 net loss of $148.8 million, versus a $80.4 million loss a year earlier, on revenue of $14.7 million up from $6.0 million. Operating expenses rose to $166.1 million, including higher R&D. Cash was about $1.48 billion. BETA raised FY revenue guidance to $42-$50 million and expects adjusted EBITDA loss of $400-$445 million.

$BETAMedAI 8/10

BETA (BETA) Q2 2026 Earnings Call Transcript

BETA Technologies’ Q2 2026 earnings call reported revenue of $14.7 million, up 146% year over year, driven by its Electrified Powertrain Flight Demonstration program and charger deliveries. Adjusted EBITDA was -$109.8 million and net loss -$148.8 million. Full-year revenue guidance was raised to $42 million to $50 million; cash was $1.5 billion. The company discussed H500A certification execution risk and MV250 military variant progress.

$BETAMed

Why is BETA Technologies stock sliding today?

BETA Technologies shares fell 4.5% in pre-open trading after the company reported Q2 2026 results before the market open. Analysts expected a 46-cent per-share loss versus a 53-cent loss in Q1. The article cites prior Q1 misses and ongoing cash burn, plus a $39 million to $43 million full-year 2026 revenue guide and an SEC Form 8-K.

$BETAHighAI 9/10

BETA Technologies, Inc. (BETA): Results of Operations and Financial Condition

BETA Technologies, Inc. (BETA) filed an SEC Form 8-K — Results of Operations and Financial Condition. BETA Technologies, Inc. Announces Second Quarter 2026 Results Delivered strong revenue growth and continued momentum across its commercial, defense and integrated aerospace platform. SOUTH BURLINGTON, Vt. – August 12, 2026 – BETA Technologies, Inc. (NYSE: BETA) (“BETA” or the “Co